Bites up, but dog count dips in corpn survey
Madurai: Amid growing complaints of stray dog menace, and dog bite casing hitting a seven-year high in the city, the latest scientific census by Madurai corporation has pegged stray dog population at 38,348, significantly lower than previous estimates.
An RTI reply had in 2021 placed the number at 53,826 in 2020, while a 2012 survey had recorded 47,573 dogs. Dog bite cases within corporation limits reached 14,130 by Nov 2024, the highest since 2018, pointing to the urgent need for effective stray management. Corporation officials, however, insist that the March 2025 enumeration is the most accurate to date, as it was conducted using scientific methods in collaboration with Worldwide Veterinary Service (WVS) and animal welfare NGO Seeshah's Kennel Foundation. The new figure for Madurai is also lower than that of Trichy corporation, which recently published a 2025 survey placing its stray dog population at 43,767. City health officer (CHO) P Indhira told TOI that Madurai's survey was carried out in all 100 wards covering five city zones. The initial groundwork and mapping were done between March 5 and 14, after which 200 student volunteers and corporation staff were trained for field enumeration. From March 17 to 23, around 300 surveys were conducted, with data collected from an average of 31% of roads in each ward. The methodology included sampling, grid mapping, training of enumerators, and multi-stage data collection. "We have done a proper survey and this is the most scientific survey. The dog count may have decreased after Covid pandemic due to decrease in number of feeders," said the CHO.The demographic breakdown revealed that 15% of the dogs were puppies (under three months), and 85% adults. Among the adults, 83% were aged over one year, and 17% were juveniles between 4 and 11 months. Male dogs accounted for 65% of the population and females, 35%, with 36% of the female dogs observed to be lactating. About 83% of the stray dogs were found to be healthy, while the remaining 17% suffered from injuries, skin infections, or other visible ailments.Madurai corporation has now announced plans to intensify sterilization and population control efforts at hotspots. Officials say the data will guide the future rollout of Animal Birth Control (ABC) and Anti-Rabies Vaccination (ARV) programmes across the city.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
23 minutes ago
- Time of India
108 Covid cases reported in 24 hrs, 461 active in Gujarat
Ahmedabad/Surat: In the 24 hours ending at 5 pm on Tuesday, the state reported 108 new Covid cases, taking the total number of active cases to 461, according to a bulletin issued by the state health department. The data indicated that out of the total active cases, 20 were hospitalised, while the remaining 441 were in home isolation. In the same period, 43 patients were discharged, and one patient succumbed to the infection, as per the bulletin. An analysis of the Covid case details from Ahmedabad city indicated that about 10-15% of the total cases are below five years of age. At least five patients were below one year in major hospitals, according to the data. "Moreover, the majority of the patients are recorded in the below 60 years or working population this wave. In comparison, the earlier waves had patients in senior citizen age categories," said a health department official. Two deaths recorded in the city were also reported in relatively younger ages — 18 and 47 years. Both were women and had comorbidities, added officials. However, a more detailed analysis of the cases may point to possible reasons for the deaths, said officials. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Mistura chinesa faz cabelo crescer e homem fica irreconhecível Resultados em 30 dias Undo "Across India, five deaths have been reported in the past 24 hours, and the reasons, as mentioned by the MoHFW website, point towards respiratory illnesses along with diabetes, hypertension, heart, and kidney diseases. The deaths recorded on the website have only one person below 50 years. Thus, the trend in Gujarat is slightly different from the one observed across India," said a city-based physician, adding that there is no need for concern, but for caution. "If the flu-like symptoms persist for more than two days, medical help should be availed." Three more persons were diagnosed with Covid in Surat Municipal Corporation (SMC) limits, which include two women aged 64 and 19 years, while the third was a 38-year-old man. The first case pertains to a 64-year-old woman from the Adajan area of Surat, who is a homemaker. She returned from Dehradun on May 29 and is currently stable in home isolation. She has a history of high blood pressure. The second case is related to a 19-year-old woman, residing in Sachin, who is a nursing student. She is currently in home isolation, and her condition is stable. A 38-year-old man, residing in Umra village, who works as a labourer, was also diagnosed with Covid infection. He is also in home isolation. Samples from these patients have been sent to GBRC, Gandhinagar, for genome sequencing as per govt guidelines. Covid positive patients in home isolation have been advised to remain isolated for five days.
Time of India
an hour ago
- Time of India
Overlapping symptoms make Cov diagnosis difficult without tests
Kolkata: The overriding symptoms of Covid during the current surge were a low-grade, persistent fever, along with a mild cough, which could be deceptive, warned doctors. While it made a vast majority ignore the symptoms and take over-the-counter medicines, for some, the fever refused to subside. It was the continuing fever that led many to consult physicians. Most of those testing Covid positive on admission to hospitals for other ailments were also screened at hospitals due to their fever. Covid cases have been rising in Bengal over the past week. The state logged 319 cases in the past seven days, taking the number of active cases to 331 on Monday. Unlike the first three waves, when Covid came with loss of smell and taste, accompanied by high fever, severe cough and pneumonia, the symptoms of the current spike were muted and flu-like, said doctors. With a runny nose and a sore throat, symptoms in most were milder than that during the pandemic, said CMRI pulmonology director Raja Dhar. "Mild symptoms led many to ignore it, which could be risky at a time, when cases are proliferating. One should get tested, and if the result turns positive, the patient should isolate, especially if there are elders in the family. Screening should be stricter for elderly people with comorbidities, and if the fever and cough persist beyond four to five days, hospitalization is advised as symptoms could worsen quickly," said Dhar. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Beyond Text Generation: An AI Tool That Helps You Write Better Grammarly Install Now Undo CMRI has seven Covid patients admitted. Manipal Hospitals infectious diseases physician Sayan Chakrabarty agreed. "The symptoms are flu-like, but for some, the fever persists. Those patients are getting tested, and many tested positive. While severe cases have been rare so far, rising numbers could lead to a spurt," he added. Five Covid patients, admitted to Manipal's different units, have been discharged. Covid pneumonia has been rare this time, said Charnock Hospital pulmonologist Soumya Sengupta. "Most patients have a cough and low fever. Even the elders in hospital who tested positive have muted Covid symptoms. Most are being treated for their comorbidities. During the pandemic, a vast majority of senior citizens had severe Covid symptoms, including pneumonia," said Sengupta. Dhar pointed out that the Jn.1 variant of the Omicron, now believed to be in circulation, was highly transmissible though less virulent. "But it is safe to isolate yourself for five days on testing positive and take symptomatic drugs. Symptoms are likely to remain mild till this wave blows over in about a fortnight. But even mild Covid may aggravate comorbidities, especially those related to lungs," he said.
Time of India
an hour ago
- Time of India
New Covid vaccine developed by USA researchers is ready to fight Coronavirus. How effective it is?
Amid fresh surge in Covid-19 cases, a team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 and H5N1. While the currently available mRNA vaccines are highly effective at inducing an immune response against Covid , they present challenges like the high amount of mRNA needed to produce them and the constantly evolving nature of the pathogen. "The virus changes, moving the goal post, and updating the vaccine takes some time," said senior author Suresh Kuchipudi, chair of Infectious Diseases and Microbiology at the University of Pittsburgh School of Public Health. To address these challenges, the researchers created a proof-of-concept Covid vaccine using what's known as a "trans-amplifying" mRNA platform. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Pare a neuropatia: descubra como NeuroFit Undo In this approach, the mRNA is separated into two fragments -- the antigen sequence and the replicase sequence -- the latter of which can be produced in advance, saving crucial time in the event a new vaccine must be developed urgently and produced at scale. In addition, the researchers analysed the spike-protein sequences of all known variants of the SARS-CoV-2 for commonalities, rendering what's known as a "consensus spike protein" as the basis for the vaccine's antigen. Live Events In mice, the vaccine induced a robust immune response against many strains of SARS-CoV-2. "This has the potential for more lasting immunity that would not require updating, because the vaccine has the potential to provide broad protection," said Kuchipudi. "Additionally, this format requires an mRNA dose 40 times less than conventional vaccines, so this new approach significantly reduces the overall cost of the vaccine." The study, published in the journal npj Vaccines could inform more efficient vaccine development for other constantly evolving RNA viruses with pandemic potential, Kuchipudi said.
